National Center for Complementary & Alternative Medicine; Notice of Meeting, 19379-19380 [2011-8314]

Download as PDF Federal Register / Vol. 76, No. 67 / Thursday, April 7, 2011 / Notices Place: NIEHS/National Institutes of Health, Building 4401, East Campus, 79 T.W. Alexander Drive, Research Triangle Park, NC 27709, (Virtual Meeting). Contact Person: RoseAnne M. McGee, Associate Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, (919) 541–0752, mcgee1@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: March 31, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 31, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–8315 Filed 4–6–11; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2011–8316 Filed 4–6–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center for Scientific Review; Notice of Meeting mstockstill on DSKH9S0YB1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Center for Scientific Review Advisory Council. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Center for Scientific Review Advisory Council. Date: May 2, 2011. Time: 8:15 a.m. to 4 p.m. Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Room E1/ E2, Bethesda, MD 20892. Contact Person: Cheryl A. Kitt, Ph.D., Executive Secretary, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3030, MSC 7776, Bethesda, MD 20892, 301–435–1112, kittc@csr.nih.gov. VerDate Mar<15>2010 19:53 Apr 06, 2011 Jkt 223001 National Center for Complementary & Alternative Medicine; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract Proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 19379 Name of Committee: National Advisory Council for Complementary and Alternative Medicine. Date: June 3, 2011. Closed: June 3, 2011, 8:30 a.m. to 10:30 a.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Open: June 3, 2011, 11 a.m. to 4 p.m. Agenda: Opening remarks by the Director of the National Center for Complementary and Alternative Medicine, presentation of a new research initiative, and other business of the Council. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: Martin H. Goldrosen, Ph.D., Executive Secretary, Director, Division of Extramural Activities, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–2014. The public comments session is scheduled from 3:30 to 4 p.m. on June 3, 2011, but could change depending on the actual time spent on each agenda item. Each speaker will be permitted 5 minutes for their presentation. Interested individuals and representatives of organizations are requested to notify Dr. Martin H. Goldrosen, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland, 20892, 301–594–2014, Fax: 301–480–9970. Letters of intent to present comments, along with a brief description of the organization represented, should be received no later than 5 p.m. on May 26, 2011. Only one representative of an organization may present oral comments. Any person attending the meeting who does not request an opportunity to speak in advance of the meeting may be considered for oral presentation, if time permits, and at the discretion of the Chairperson. In addition, written comments may be submitted to Dr. Martin H. Goldrosen at the address listed above up to ten calendar days (June 13, 2011) following the meeting. Copies of the meeting agenda and the roster of members will be furnished upon request by contacting Dr. Martin H. Goldrosen, Executive Secretary, NACCAM, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–594– 2014, Fax 301–480–9970, or via e-mail at naccames@mail.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: nccam.nih.gov/about/naccam, where an E:\FR\FM\07APN1.SGM 07APN1 19380 Federal Register / Vol. 76, No. 67 / Thursday, April 7, 2011 / Notices agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.701, ARRA Related Biomedical Research and Research Support Awards; 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Dated: April 1, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–8314 Filed 4–6–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of Proposed Project: 2012 National Survey on Drug Use and Health—(OMB No. 0930–0110)—Revision The National Survey on Drug Use and Health (NSDUH) is a survey of the civilian, non-institutionalized population of the United States 12 years old and older. The data are used to determine the prevalence of use of tobacco products, alcohol, illicit substances, and illicit use of prescription drugs. The results are used by SAMHSA, ONDCP, Federal government agencies, and other organizations and researchers to establish policy, direct program activities, and better allocate resources. The 2012 and 2013 NSDUHs will continue conducting a follow-up clinical interview with a subsample of approximately 1,500 respondents. The design of this Mental Health Surveillance Study (MHSS) is based on the recommendations from a panel of expert consultants convened by the Center for Mental Health Services (CMHS), SAMHSA, to discuss mental health surveillance data collection strategies. The goal is to create a statistically sound measure that may be used to estimate the prevalence of Serious Mental Illness (SMI) among adults (age 18+). For the 2012 and 2013 NSDUHs, no questionnaire changes are proposed. As with all NSDUH/NHSDA surveys conducted since 1999, the sample size of the survey for 2012 and 2013 will be sufficient to permit prevalence estimates for each of the fifty states and the District of Columbia. The total annual burden estimate is shown below: ESTIMATED ANNUAL BURDEN FOR 2012/2013 NSDUH Responses per respondent No. of respondents Instrument Hours per response Total burden hours Hourly wage rate Annualized hourly costs Household Screening ............................... Interview ................................................... Clinical Follow-up Certification ................. Clinical Follow-up Interview ..................... Screening Verification .............................. Interview Verification ................................ 191,100 67,500 90 1,500 5,400 10,125 1 1 1 1 1 1 0.083 1.000 1.000 1.000 0.067 0.067 15,861 67,500 90 1,500 362 678 $14.71 14.71 14.71 14.71 14.71 14.71 $233,315 992,925 1,324 22,065 5,325 9,973 Total .................................................. 191,190 ........................ ........................ 85,991 ........................ 1,264,927 Send comments to Summer King, SAMHSA Reports Clearance Officer, Room 8–1099, One Choke Cherry Road, Rockville, MD 20857 And e-mail a copy to summer.king@samhsa.hhs.gov. Written comments should be received within 60 days of this notice. mstockstill on DSKH9S0YB1PROD with NOTICES Dated: March 30, 2011. Elaine Parry, Director, Office of Management, Technology and Operations. DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2011–0187] VerDate Mar<15>2010 19:53 Apr 06, 2011 ACTION: The Coast Guard announces the date for the entry into effect of discharge requirements from ships in the Wider Caribbean Region (WCR) special area (SA) as specified in the International Convention for the Prevention of Pollution from Ships PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 The docket for this notice is available for inspection or copying at the Docket Management Facility (M–30), U.S. Department of Transportation, West Building Ground Floor, Room W12–140, 1200 New Jersey Avenue SE., Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. You may also find this docket on the Internet by going ADDRESSES: Coast Guard, DHS. Notice. AGENCY: SUMMARY: Jkt 223001 IMO Resolution MEPC.191(60) established the date of entry for discharge requirements in the WCR SA as May 1, 2011. DATES: Notice of Entry Into Effect of MARPOL Annex V Wider Caribbean Region Special Area [FR Doc. 2011–8293 Filed 4–6–11; 8:45 am] BILLING CODE 4162–20–P (MARPOL) Annex V, Regulation 5 and Coast Guard regulations. MARPOL Annex V and the U.S. regulations apply to vessel and reception facility activities in the WCR region. E:\FR\FM\07APN1.SGM 07APN1

Agencies

[Federal Register Volume 76, Number 67 (Thursday, April 7, 2011)]
[Notices]
[Pages 19379-19380]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8314]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the National Advisory 
Council for Complementary and Alternative Medicine (NACCAM) meeting.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract Proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable materials, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Complementary 
and Alternative Medicine.
    Date: June 3, 2011.
    Closed: June 3, 2011, 8:30 a.m. to 10:30 a.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Open: June 3, 2011, 11 a.m. to 4 p.m.
    Agenda: Opening remarks by the Director of the National Center 
for Complementary and Alternative Medicine, presentation of a new 
research initiative, and other business of the Council.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Martin H. Goldrosen, Ph.D., Executive Secretary, 
Director, Division of Extramural Activities, National Center for 
Complementary and Alternative Medicine, National Institutes of 
Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 
594-2014.

    The public comments session is scheduled from 3:30 to 4 p.m. on 
June 3, 2011, but could change depending on the actual time spent on 
each agenda item. Each speaker will be permitted 5 minutes for their 
presentation. Interested individuals and representatives of 
organizations are requested to notify Dr. Martin H. Goldrosen, 
National Center for Complementary and Alternative Medicine, NIH, 
6707 Democracy Boulevard, Suite 401, Bethesda, Maryland, 20892, 301-
594-2014, Fax: 301-480-9970. Letters of intent to present comments, 
along with a brief description of the organization represented, 
should be received no later than 5 p.m. on May 26, 2011. Only one 
representative of an organization may present oral comments. Any 
person attending the meeting who does not request an opportunity to 
speak in advance of the meeting may be considered for oral 
presentation, if time permits, and at the discretion of the 
Chairperson. In addition, written comments may be submitted to Dr. 
Martin H. Goldrosen at the address listed above up to ten calendar 
days (June 13, 2011) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by contacting Dr. Martin H. Goldrosen, 
Executive Secretary, NACCAM, National Center for Complementary and 
Alternative Medicine, National Institutes of Health, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax 
301-480-9970, or via e-mail at naccames@mail.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: nccam.nih.gov/about/naccam, where an

[[Page 19380]]

agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.701, ARRA 
Related Biomedical Research and Research Support Awards; 93.213, 
Research and Training in Complementary and Alternative Medicine, 
National Institutes of Health, HHS)

    Dated: April 1, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-8314 Filed 4-6-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.